BAY94-9343
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BAY94-9343, covering 2018-06-04 to 2018-06-04. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Dose Escalation Study of BAY94-9343 Given by Intravenous Infusion Every 3 Weeks in Japanese Subjects With Advanced Malignancies [Phase 1]